The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
The global Metabolomics market was valued at US$ 2136 million in 2023 and is anticipated to reach US$ 4868.7 million by 2030, witnessing a CAGR of 12.9% during the forecast period 2024-2030.
The key manufacturers of Metabolomics include Thermo Fisher, Agilent, Metabolon, Shimadzu, Corporation, Bruker, Waters Corporation, etc. Among them, Thermo Fisher and Agilent rank first and second in the world market share, about 12% and 9% respectively.
The market of metabolomics is distributed all over the world, with North America, Europe and Asia Pacific as the major markets. The North American market share reached more than 40%, ranking first in the world.
In terms of product, it include Metabolomics Instruments as well as Bioinformatics Tools and Services. The world market share of the two parts is about 2:1. It is expected that Bioinformatics Tools and Services' market share will increase relatively in the future.
Metabolomics is mainly used in academic and research institutes, pharmaceutical and biotechnology companies, contract research organizations, and other institutional organizations. Among them, academic and research institutions occupy the highest market share, accounting for more than 45%. In the Chinese market, the share of academic and research institutions has reached more than 50%.
This report aims to provide a comprehensive presentation of the global market for Metabolomics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Metabolomics.
Report Scope
The Metabolomics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Metabolomics market comprehensively. Regional market sizes, concerning products by Type, by End User, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Metabolomics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by End User, and by regions.
Market Segmentation
By Company (Partial List)
- Thermo Fisher
- Agilent
- Metabolon
- Shimadzu Corporation
- Bruker
- Waters Corporation
- Biotree
- LECO Corporation
- Biocrates Life Sciences AG
- Human Metabolome Technologies
- Metware
- Applied Protein Technology
- Creative Proteomics
- Diagnostic Solutions Laboratory
Segment by Type
- Metabolomics Instruments
- Bioinformatics Tools and Services
Segment by End User
- Academic and Research Institutes
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina)
- Middle East & Africa (Turkey, Saudi Arabia, UAE)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by End User, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Metabolomics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by End User, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Metabolomics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Metabolomics Instruments
1.2.3 Bioinformatics Tools and Services
1.3 Market by End User
1.3.1 Global Metabolomics Market Growth by End User: 2019 VS 2023 VS 2030
1.3.2 Academic and Research Institutes
1.3.3 Pharmaceutical and Biotechnology Companies
1.3.4 Contract Research Organizations
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Metabolomics Market Perspective (2019-2030)
2.2 Metabolomics Growth Trends by Region
2.2.1 Global Metabolomics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Metabolomics Historic Market Size by Region (2019-2024)
2.2.3 Metabolomics Forecasted Market Size by Region (2025-2030)
2.3 Metabolomics Market Dynamics
2.3.1 Metabolomics Industry Trends
2.3.2 Metabolomics Market Drivers
2.3.3 Metabolomics Market Challenges
2.3.4 Metabolomics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Metabolomics Players by Revenue
3.1.1 Global Top Metabolomics Players by Revenue (2019-2024)
3.1.2 Global Metabolomics Revenue Market Share by Players (2019-2024)
3.2 Global Metabolomics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Metabolomics Revenue
3.4 Global Metabolomics Market Concentration Ratio
3.4.1 Global Metabolomics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Metabolomics Revenue in 2023
3.5 Metabolomics Key Players Head office and Area Served
3.6 Key Players Metabolomics Product Solution and Service
3.7 Date of Enter into Metabolomics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Metabolomics Breakdown Data by Type
4.1 Global Metabolomics Historic Market Size by Type (2019-2024)
4.2 Global Metabolomics Forecasted Market Size by Type (2025-2030)
5 Metabolomics Breakdown Data by End User
5.1 Global Metabolomics Historic Market Size by End User (2019-2024)
5.2 Global Metabolomics Forecasted Market Size by End User (2025-2030)
6 North America
6.1 North America Metabolomics Market Size (2019-2030)
6.2 North America Metabolomics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Metabolomics Market Size by Country (2019-2024)
6.4 North America Metabolomics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Metabolomics Market Size (2019-2030)
7.2 Europe Metabolomics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Metabolomics Market Size by Country (2019-2024)
7.4 Europe Metabolomics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Metabolomics Market Size (2019-2030)
8.2 Asia-Pacific Metabolomics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Metabolomics Market Size by Region (2019-2024)
8.4 Asia-Pacific Metabolomics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Metabolomics Market Size (2019-2030)
9.2 Latin America Metabolomics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Metabolomics Market Size by Country (2019-2024)
9.4 Latin America Metabolomics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Metabolomics Market Size (2019-2030)
10.2 Middle East & Africa Metabolomics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Metabolomics Market Size by Country (2019-2024)
10.4 Middle East & Africa Metabolomics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher
11.1.1 Thermo Fisher Company Detail
11.1.2 Thermo Fisher Business Overview
11.1.3 Thermo Fisher Metabolomics Introduction
11.1.4 Thermo Fisher Revenue in Metabolomics Business (2019-2024)
11.1.5 Thermo Fisher Recent Development
11.2 Agilent
11.2.1 Agilent Company Detail
11.2.2 Agilent Business Overview
11.2.3 Agilent Metabolomics Introduction
11.2.4 Agilent Revenue in Metabolomics Business (2019-2024)
11.2.5 Agilent Recent Development
11.3 Metabolon
11.3.1 Metabolon Company Detail
11.3.2 Metabolon Business Overview
11.3.3 Metabolon Metabolomics Introduction
11.3.4 Metabolon Revenue in Metabolomics Business (2019-2024)
11.3.5 Metabolon Recent Development
11.4 Shimadzu Corporation
11.4.1 Shimadzu Corporation Company Detail
11.4.2 Shimadzu Corporation Business Overview
11.4.3 Shimadzu Corporation Metabolomics Introduction
11.4.4 Shimadzu Corporation Revenue in Metabolomics Business (2019-2024)
11.4.5 Shimadzu Corporation Recent Development
11.5 Bruker
11.5.1 Bruker Company Detail
11.5.2 Bruker Business Overview
11.5.3 Bruker Metabolomics Introduction
11.5.4 Bruker Revenue in Metabolomics Business (2019-2024)
11.5.5 Bruker Recent Development
11.6 Waters Corporation
11.6.1 Waters Corporation Company Detail
11.6.2 Waters Corporation Business Overview
11.6.3 Waters Corporation Metabolomics Introduction
11.6.4 Waters Corporation Revenue in Metabolomics Business (2019-2024)
11.6.5 Waters Corporation Recent Development
11.7 Biotree
11.7.1 Biotree Company Detail
11.7.2 Biotree Business Overview
11.7.3 Biotree Metabolomics Introduction
11.7.4 Biotree Revenue in Metabolomics Business (2019-2024)
11.7.5 Biotree Recent Development
11.8 LECO Corporation
11.8.1 LECO Corporation Company Detail
11.8.2 LECO Corporation Business Overview
11.8.3 LECO Corporation Metabolomics Introduction
11.8.4 LECO Corporation Revenue in Metabolomics Business (2019-2024)
11.8.5 LECO Corporation Recent Development
11.9 Biocrates Life Sciences AG
11.9.1 Biocrates Life Sciences AG Company Detail
11.9.2 Biocrates Life Sciences AG Business Overview
11.9.3 Biocrates Life Sciences AG Metabolomics Introduction
11.9.4 Biocrates Life Sciences AG Revenue in Metabolomics Business (2019-2024)
11.9.5 Biocrates Life Sciences AG Recent Development
11.10 Human Metabolome Technologies
11.10.1 Human Metabolome Technologies Company Detail
11.10.2 Human Metabolome Technologies Business Overview
11.10.3 Human Metabolome Technologies Metabolomics Introduction
11.10.4 Human Metabolome Technologies Revenue in Metabolomics Business (2019-2024)
11.10.5 Human Metabolome Technologies Recent Development
11.11 Metware
11.11.1 Metware Company Detail
11.11.2 Metware Business Overview
11.11.3 Metware Metabolomics Introduction
11.11.4 Metware Revenue in Metabolomics Business (2019-2024)
11.11.5 Metware Recent Development
11.12 Applied Protein Technology
11.12.1 Applied Protein Technology Company Detail
11.12.2 Applied Protein Technology Business Overview
11.12.3 Applied Protein Technology Metabolomics Introduction
11.12.4 Applied Protein Technology Revenue in Metabolomics Business (2019-2024)
11.12.5 Applied Protein Technology Recent Development
11.13 Creative Proteomics
11.13.1 Creative Proteomics Company Detail
11.13.2 Creative Proteomics Business Overview
11.13.3 Creative Proteomics Metabolomics Introduction
11.13.4 Creative Proteomics Revenue in Metabolomics Business (2019-2024)
11.13.5 Creative Proteomics Recent Development
11.14 Diagnostic Solutions Laboratory
11.14.1 Diagnostic Solutions Laboratory Company Detail
11.14.2 Diagnostic Solutions Laboratory Business Overview
11.14.3 Diagnostic Solutions Laboratory Metabolomics Introduction
11.14.4 Diagnostic Solutions Laboratory Revenue in Metabolomics Business (2019-2024)
11.14.5 Diagnostic Solutions Laboratory Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
